COMPUGEN LTD (CGEN) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-27

Key Insights

CEO Ophir Eran executed a net sale of 5,000 ordinary shares on 04/24/2026, selling at an average price of $3.20 while simultaneously purchasing 5,000 shares at $0.83, indicating a structured arbitrage or equity compensation exercise rather than conviction-based selling.
The transaction was executed under a Rule 10b5-1 trading plan adopted on 12/26/2025, suggesting these trades were pre-planned and automatic rather than based on current market conditions or material non-public information.
Following the transactions, Eran's beneficial ownership increased from 11,375 to 16,375 ordinary shares, demonstrating net accumulation of company stock despite the sale activity, which is moderately bullish for insider confidence.
The CEO received 5,000 stock options with a $0.8292 exercise price expiring 11/09/2032, vesting quarterly through continued service, representing long-term compensation alignment with shareholder interests.

Want the newest filings?

This analysis covers the filing from 2026-04-27. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-27

SVP of Business Development Zurit Levine executed a net sell transaction, disposing of 2,000 shares at $3.20 while acquiring 2,000 shares at $1.15 on the same day (04/24/2026), resulting in a net neutral position change but realizing a $4,100 gain
The transaction was executed under a Rule 10b5-1 trading plan adopted on December 23, 2025, indicating pre-planned systematic trading rather than opportunistic insider activity, which reduces the significance of the directional signal
Levine retains 29,375 ordinary shares directly and holds 52,000 unexercised share options vesting through August 2033, demonstrating continued material stake in the company despite the sell activity
The sell price of $3.20 significantly exceeds the concurrent buy price of $1.15, suggesting the shares sold may have been from a different grant or incentive program, though the mechanics warrant clarification

Filed: 2026-04-15

The reporting person, Zurit Levine, exercised 2,000 stock options and immediately sold the same amount of shares, indicating some insider selling activity.
Levine continues to hold 29,375 ordinary shares and 54,000 unexercised stock options in the company.
The transactions were made pursuant to a Rule 10b5-1 trading plan, which suggests pre-planned and potentially routine trading behavior.

Filed: 2026-04-15

Ophir Eran, the President and CEO of Compugen Ltd., has exercised 5,000 stock options and sold 5,000 ordinary shares, indicating some insider selling activity.
The stock sale was done at a weighted average price of $2.9042 per share, which appears to be at a premium to the exercise price of $0.8292 per share for the options.
Eran still holds 11,375 ordinary shares directly after the reported transactions, indicating he continues to maintain a significant equity stake in the company.

Filed: 2026-04-13

Zurit Levine, SVP of Business Development at Compugen, exercised share options and sold a portion of the shares, indicating potential insider selling activity.
Levine exercised 1,125 options with a strike price of $0.8292 and 2,000 options with a strike price of $1.15, suggesting he believes the current share price offers an attractive opportunity to realize gains.
The weighted average sale price of $2.564 for the 3,125 shares sold suggests Levine may have a positive view on Compugen's current valuation and is taking advantage of the stock's recent performance.

Filed: 2026-04-09

The SEC Form 4 filing shows that Zurit Levine, SVP of Business Development at Compugen Ltd. (CGEN), has been actively exercising and selling company stock options on April 7th and 8th, 2026.
Levine exercised a total of 7,875 stock options at exercise prices of $0.8292 and $1.15, and subsequently sold 7,875 shares at prices between $2.30 and $2.42.
The transactions appear to be part of a pre-planned 10b5-1 trading plan, indicating Levine's intention to liquidate a portion of his holdings on a regular basis.

Filed: 2026-04-03

Ophir Eran, the President and CEO of Compugen Ltd, exercised 5,625 stock options at $0.8292 per share and immediately sold 5,625 shares at an average price of $2.2067 per share, indicating insider selling activity.
Eran's transactions were made pursuant to a 10b5-1 trading plan, suggesting the sales were part of a pre-planned strategy rather than opportunistic trading.
The reported transactions represent a relatively small portion of Eran's total beneficial ownership in Compugen, as he still holds 11,375 shares directly following the reported transactions.

Filed: 2026-04-03

The reporting person, Zurit Levine, is exercising a significant number of stock options, indicating they believe in the company's long-term prospects.
Levine is also selling a portion of their shares, likely to diversify their portfolio or for personal reasons, but the sell volume is relatively low compared to the options exercised.
The options exercised have varying vesting schedules, suggesting Levine has been with the company for several years and has a long-term commitment to COMPUGEN LTD.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.